Search

The article introduces Postnova Analytics, the exclusive manufacturer of a comprehensive range of Field-Flow Fractionation (FFF) systems, including Flow FFF, Thermal FFF, Centrifugal FFF, and SPLITT FFF. FFF technology, applicable in various fields such as nanotechnology, nanomedicine, biotechnology, food, polymer, and environmental sciences. It also provides fast, gentle, and high-resolution separations of macromolecules or particles in liquid media, serving as a reliable alternative.

However, users may print, download, or email articles for individual use. 4/2/2021 Digital Edition- IFT Sign In- December 2018 https://foodtechnology.ift.org/publication/?m=46537&i=546143&p=1 22/88 4/2/2021 Digital Edition- IFT Sign In- December 2018 https://foodtechnology.ift.org/publication/?m=46537&i=546143&p=1 23/88 4/2/2021 Digital Edition- IFT Sign In- December 2018 https://foodtechnology.ift.org/publication/?m=46537&i=546143&p=1 25/88 4/2/2021 Digital Edition- IFT Sign In- December 2018 https://foodtechnology.ift.org/publication/?m=46537&i=546143&p=1 26/88 4/2/2021 Digital Edition- IFT Sign In- December 2018 https://foodtechnology.ift.org/publication/?m=46537&i=546143&p=1 28/88 4/2/2021 Digital Edition- IFT Sign In- December 2018 https://foodtechnology.ift.org/publication/?m=46537&i=546143&p=1 29/88 Copyright of Food Technology is the property of Institute of Food Technologists and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. [Extracted from the article]

The article looks at the viability of current nanomedicine as drug delivery system, to target cancerous tumor. Topics discussed include doubt on efficiency of drug delivery preventing the development of new cancer nanomedicines, less chances of nanomedicines interacting with healthy tissue and causing unwanted toxicity, and enhancement of permeability and retention (EPR) effect.

The article presents an interview with Christoph Johann, Global Product Manager Wyatt Technology, on field-flow fractionation (FFF) offering a solution for the characterization of sub-micron particles and macromolecules. Topics include clarify what FFF means for Wyatt and seems to methods and techniques go by name; and have the product manager for FFF why has Wyatt investing in FFF.

The article discusses the developments in the ceramics industry, particularly on the nanoceramic sensors for medical applications. It focuses on the fabrication of one-dimensional nanoceramics and their emergence as feasible solutions for noninvasive medical diagnostics. It claims that ceramic sensor technology and nanomedicine can be used in conducting breath-based diagnostics. INSET: Center for Nanomaterials and Sensor Development.

The article focuses on the nanoparticle-based therapies for the treatment of cancer. It reports that nanoscale particles can slip into tumors and individual cancer cells without damaging healthy tissues. It highlights a treatment called CRLX101 which has shown promise in the treatment of lung cancer and is currently under phase 2 clinical trials.

The article focuses on Design-Bid-Build (DBB). It mentions the Heating, ventilation, and air conditioning (HVAC) design criteria shall be in sync with the project delivery method and the owner' building program requirements; and also mentions the new central plant hot water system shall include primary pumps per boiler and secondary pumps with variable frequency drives (VFDs).

The article presents information on use of nanotechnology in treating several eye diseases. It defines nanomedicines as a technology of diagnosing, preventing, and treating diseases to improve human health. It informs that liposome's and micelles which are nanoscale particles are significantly used in ocular tension-lowering medications. It informs that nanoparticles can also be used as a carrier for antibiotics as they can enter into bacterial membrane and kill bacteria's.

The article offers information on a new cooling tower to serve a pharmaceutical facility's new process water system. It mentions that the tower will have a floor-mounted end suction condenser water pump, and a second pump will serve as a standby and also highlights the design team that includes the HVAC, structural, plumbing, and electrical consultants, and the HVAC consulting engineer.

The article offers information on a technique to deliver nanomedicines in the cancer tumor tissues through leaking tumor blood vessels. Topics discussed include reduction in side effects of cancer drugs by delivering nanoparticle directly into the tumor, the therapy's success depend on the tumor's ability to uptake and retain the drug, and formation of loose junctions in blood vessels of tumors due to their fast growth.

A letter to the editor in response to the article "Does Nanomedicine Have a Delivery Problem" in the June 20, 2016 issue is presented.

The article presents the research of market intelligence company Transparency Market Research Pvt. Ltd. on the projected growth of the nanomedicine. The topics discussed include the poised numerous years of growth of nanomedicine until 2019, the partnership between Ireland and the U.S. for the development of pancreatic cancer treatments, and the study carried out by Georgia State University researcher on the use of nanoparticles in the vaccination of respiratory syncytial virus (RSV).

The article reports on the release of the nanomedicine which has various applications in ophthalmology because of its potential to design living structures to solve mechanical problems. The ophthalmic applications include tissue repair and vision restoration, development of contract enhancement agents, and stop bleeding in the eye during surgery. However, the technology is not ready for testing in humans but it shows improvements in animal experiments such as prevention of eye diseases.

The article discusses a study by researcher José A. Garcia-Salcedo and others, published in the periodical "PLOS Pathogens" in 2015, on development of pentamidine-loaded chitosan nanoparticle as drug therapies for the parasitic infection African trypanosomiasis.

The article discusses a research study which reports that polyvinyl alcohol (PVA) nanowafers loaded with the antiangiogenic drug axitinib were more effective in treating corneal neovascularization (CNV) compared with axitinib eye drops.

The article focuses on a study by scientist Davide Moscatelli et al. in the journal "ACS Nano" in 2013, according to which drug such as minocycline-laden polymer nanoparticles can easily get inside microglia, inflammation-causing cells, and nanoparticles can disperse their payload after ingestion.

The article offers information on the 2014 Nanomedicine Conference to be held in San Francisco, California, in February 2014.

The article offers information on nanomedicines that are capable of finding tumors and delivering chemotherapeutics only to cells where they're needed in the human body.

The article discusses a study published in "ACS Nano" about U.S. biomedical engineers' development of nanoscale particles that can be injected into the body to automatically release insulin at high glucose levels.

The article reports on the failure of the hip replacement equipments and reports that the failure is attributed to the nanoparticle debris which is generated when the pieces of cobalt-chromium alloy metal-on metal hip replacements come together.

The article reflects on article on nanomedicine by Guy M. Genin and Ram V. Devireddy, published within the issue. Genin and Devireddy talk about a previous article titled The Great Out of the Small, which introduced the potential of nano-engineering. It focuses on how nanotechnology could transform industries and revolutionize the medical and biomechanical fields. It highlights Rita Gunther McGrath's article published in other journal, on companies approach of adopting new technologies.

The article reports that a group of researchers, which include Sujatha Kannan of Johns Hopkins University, has developed a dendrimer-drug nanomedicine that could treat brain inflammation associated with cerebral palsy.

The article discusses some developments in treating glaucoma. Medical therapy remains the mainstay for treating glaucoma with the introduction of preservative-free prostaglandin analog including tafluprost and dorzolamide and the release of generic versions of latanoprost. In the field of drug delivery, scientists are seeking new ways to apply glaucoma treatment through nanotechnology and nanomedicine.